Correlation Between Vascular Biogenics and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Vascular Biogenics and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vascular Biogenics and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vascular Biogenics and Inozyme Pharma, you can compare the effects of market volatilities on Vascular Biogenics and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vascular Biogenics with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vascular Biogenics and Inozyme Pharma.
Diversification Opportunities for Vascular Biogenics and Inozyme Pharma
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Vascular and Inozyme is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Vascular Biogenics and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Vascular Biogenics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vascular Biogenics are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Vascular Biogenics i.e., Vascular Biogenics and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Vascular Biogenics and Inozyme Pharma
If you would invest 257.00 in Inozyme Pharma on October 7, 2024 and sell it today you would earn a total of 50.00 from holding Inozyme Pharma or generate 19.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 5.0% |
| Values | Daily Returns |
Vascular Biogenics vs. Inozyme Pharma
Performance |
| Timeline |
| Vascular Biogenics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Inozyme Pharma |
Vascular Biogenics and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vascular Biogenics and Inozyme Pharma
The main advantage of trading using opposite Vascular Biogenics and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vascular Biogenics position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Vascular Biogenics vs. Revelation Biosciences | Vascular Biogenics vs. Zura Bio Limited | Vascular Biogenics vs. Phio Pharmaceuticals Corp | Vascular Biogenics vs. ZyVersa Therapeutics |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |